CLAIM #22911 · EMR (EMR) · 2025Q3 earnings call · Aug 6, 2025 · due Sep 30, 2025
“But overall, we feel very, very good about the high end of the 4% to 7% range for underlying growth in our systems and software business.”
Ram Krishnan · COO
In context
“about the Total deal pulling into Q2, which would have been in Q3 and Aspen's -- Emerson Q3, their Q4 was traditionally their biggest. So we have that movement. But underlying Aspen ACV growth and continued revenue growth, very strong this year. And then the systems business continues to do very well in the mid-single digits and continues to see all the dynamics that Lal and Ram have talked about. Ram R. Krishnan: Yes. Yes, I think you said it. I think overall, from a full year perspective, mid-single-digit growth plus in the systems and software business. But as Mike described, the lumpiness associated with how Aspen recognizes ASC 606 with the Total, for example, as well as project lumpiness and how we execute within systems and software will have variations from 1 quarter to the next. But overall, we feel very, very good about the high end of the 4% to 7% range for underlying growth in our systems and software business. Joseph John O'Dea: Great. That's helpful. And then just a little bit more color on the discrete side of the business and kind of contrasting Test & Measurement with legacy discrete. You did see order acceleration there in Test & Measurement. It looks like discrete orders may be pacing more flattish. And so what you're seeing in the different demand trends there and your expectation for kind of legacy discrete recovery? Surendralal Lanca Karsanbhai: I'll start off, and Ram can add some color. So there are 2 very important dimensions of the legacy discrete, Joe, that differ from Test & Measurement. The first is exposure to automotive and packaging businesses, particularly in Western Europe and China. And both of those markets continue to be relatively depressed and challenging and that cert”
Verify independently
SEC filings for EMR ↗ · Claim quote is verbatim from the 2025Q3 earnings call.